News & Articles

Help us celebrate the best new clinical assays, kits, instruments and devices by casting your vote today

Join this webinar to learn about the benefits of automated urinalysis and the methods behind it

How to create a cost-effective, centralized informatics environment, whilst conforming with ISO guidelines

A mass spec scientist, from a world-renowned clinical pathology laboratory, shares the secrets to their success in this exclusive SelectScience interview

The novel diagnostics device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics

Don’t miss April’s highlights thanks to our regular monthly round-up of all the most popular stories and resources in the clinical science community

This new solution could enable large-scale AAV vector production for gene therapy

Next-generation assay aids in diagnosing heart attacks faster and more accurately, and is enabled on the company’s newest analyzer, the VITROS® XT 7600 Integrated System

New system promises to deliver antibiotic susceptibility testing results in two hours to help avoid misuse of antibiotics in suspected sepsis patients

Scientists based at the Moscow Institute of Physics and Technology have designed a portable device for rapid correction of hemostasis abnormalities – SelectScience editors find out more

New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer

Optical topography to reduce patient burden in the treatment of attention-deficit hyperactivity disorder

Dr. Jim Aguanno explores the role of natriuretic peptides – NT-proBNP and BNP – in the diagnosis of heart failure

SelectScience is hosting two free CE-accredited events for healthcare professionals and laboratory scientists, but hurry - spots are filling up fast!

New molecular assay enables rapid antibiotic resistance result to support use of cost effective and convenient oral antibiotic for gonorrhea treatment

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission

Simplexa™ GBS Direct molecular assay enables in vitro detection of Group B Streptococcus